For future studies, it would be interesting to investigate if C3F could show other biomarker properties like those of FAP protein quantification as multiple studies have shown an indication of its prognostic or predictive potential in multiple cancer types including renal, colorectal, hepatic, and lung cancer [25,58,59,60]. This evidence concerns the gene LPCAT3 and lung cancer.